Skip to main content

Want a detailed portfolio tracker?

Viatris (VTRS) Debt to Equity (2019 - 2026)

Viatris (VTRS) debt to equity from Dec 31, 2019 to Mar 31, 2026. The current Viatris (VTRS) debt to equity is 97.86%. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Debt to Equity

Debt to Equity

Annual Debt to Equity change of Viatris (VTRS)

YearDebt to EquityChange
202597.98%
+29.98%
202475.38%
-14.91%
202388.59%
-3.15%
202291.47%
-13.20%
2021105.38%
-2.22%
2020107.77%
-100.00%
2019Infinity%
N/A

Comparison Viatris (VTRS) debt to equity with competitors

Viatris (VTRS) debt to equity is 97.86%.

TickerNameDebt to EquityUpside
LNTHLantheus Holdings Inc0.07%-99.93%
BIOABioAge Labs Inc0.31%-99.69%
CRDLCardiol Therapeutics Inc - Class A0.48%-99.51%
TLRYTilray Brands Inc0.57%-99.42%
SXTCChina SXT Pharmaceuticals Inc0.68%-99.30%
OGIOrganiGram Holdings Inc2.20%-97.75%
UPCUniverse Pharmaceuticals Inc3.75%-96.16%
CPHIChina Pharma Holdings Inc3.96%-95.95%
ZYBTZhengye Biotechnology Holding Ltd4.10%-95.81%
KMDAKamada Ltd4.49%-95.41%
APUSApimeds Pharmaceuticals US Inc6.13%-93.74%
HCMHUTCHMED (China) Ltd7.60%-92.23%
ACBAurora Cannabis Inc18.83%-80.76%
TKNOAlpha Teknova Inc20.29%-79.27%
RDYDr. Reddy`s Laboratories Ltd20.51%-79.04%
RMTIRockwell Medical Inc24.86%-74.60%
GELSGelteq Ltd26.68%-72.73%
CGCCanopy Growth Corporation29.68%-69.68%
TEVATeva- Pharmaceutical Industries Ltd31.60%-67.71%
AYTUAytu BioPharma Inc32.46%-66.84%
INCRINC Research Holdings Inc46.15%-52.84%
ASRTAssertio Holdings Inc51.89%-46.97%
HLNHaleon plc52.41%-46.44%
PBHPrestige Consumer Healthcare Inc52.66%-46.19%
ANIPANI Pharmaceuticals Inc54.29%-44.52%
EVOEvotec SE55.38%-43.41%
PCRXPacira BioSciences Inc56.23%-42.55%
ELANElanco Animal Health Inc57.48%-41.27%
DERMJourney Medical Corp82.30%-15.91%
ALKSAlkermes plc86.23%-11.89%
ETONEton Pharmaceuticals Inc100.43%+2.62%
EBSEmergent Biosolutions Inc109.65%+12.05%
PRGOPerrigo Company plc145.37%+48.54%
PAHCPhibro Animal Health Corp - Class A171.50%+75.24%
AKBAAkebia Therapeutics Inc178.59%+82.49%
ZTSZoetis Inc - Class A279.77%+185.88%
HROWHarrow Inc1045.08%+967.89%
XERSXeris Biopharma Holdings Inc1700.28%+1637.40%
TAKTakeda Pharmaceutical CompanyInfinity%+Infinity%